🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate the safety and efficacy of SL19+22 in patients with relapsed or...
Status
Unknown
Location
Hebei Yanda Ludaopei Hospital
Start Date
2021-05-01
Trial ID
NCT05206071
Treatments Being Tested
This study aims to evaluate safety and efficacy of a combination of 4th gen...
Status
Not Yet Recruiting
Location
Shenzhen Geno-Immune Medical Institute
Start Date
2027-06-01
Trial ID
NCT04429438
Treatments Being Tested
The purpose of this study is to test the safety and efficacy of AUTO3, a CA...
Status
Completed
Location
Great Ormond Street Hospital for Children NHS Foundation Trust
Start Date
2017-06-26
Trial ID
NCT03289455
Treatments Being Tested
This is a Phase II open-label, two-arm randomised non-comparative, multi-ce...
Status
Recruiting
Location
Royal Prince Alfred Hospital
Start Date
2024-05-14
Trial ID
NCT06414148
Treatments Being Tested
Clinical studies of CD19 CAR-T cells in the treatment of blood and lymphati...
Status
Withdrawn
Location
Zhujiang Hospital of Southern Medical University
Start Date
2017-12-30
Trial ID
NCT03098355
Treatments Being Tested
This is a single center, non-randomized, open-label, phase 2 study to evalu...
Status
Completed
Location
The First Affiliated Hospital of Soochow University
Start Date
2020-08-01
Trial ID
NCT04539444
Treatments Being Tested
This study is a single-armed, open-label,multicenter Phase 1/2 study to eva...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2021-10-20
Trial ID
NCT05091541
Treatments Being Tested
This is a single center, open-label ,phase 1/2 study to evaluate the safety...
Status
Unknown
Location
The First Affiliated Hospital of Soochow University
Start Date
2017-09-01
Trial ID
NCT03614858
Treatments Being Tested
This phase I trial tests the safety, side effects and best dose of anti-CD1...
Status
Active Not Recruiting
Location
Ohio State University Comprehensive Cancer Center
Start Date
2026-01-14
Trial ID
NCT07166419
The purpose of this study is to estimate the safety and the efficacy of ant...
Status
Not Yet Recruiting
Location
State Institution Minsk Scientific and Practical Center for Surgery, Transplantology, and Dermatology
Start Date
2026-01-01
Trial ID
NCT07162571
Treatments Being Tested